These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tyrosinemia type II with incomplete Richner-Hanhart's syndrome. Lestringant GG Int J Dermatol; 1988; 27(1):43-4. PubMed ID: 2964425 [No Abstract] [Full Text] [Related]
24. [Tyrosinemia type II. Case report]. Benatiya AI; Bouayed MA; Touiza E; Daoudi K; Bhalil S; Elmesbahi I; Tahri H Bull Soc Belge Ophtalmol; 2005; (296):57-61. PubMed ID: 16050420 [TBL] [Abstract][Full Text] [Related]
25. [Oculo-cutaneous tyrosinosis (Richner-Hanhart syndrome). Histo-pathological study of a case]. Larregue M; de Giacomoni P; Odievre M; Babin P; Lorette G Ann Anat Pathol (Paris); 1980; 25(3):185-200. PubMed ID: 6112939 [TBL] [Abstract][Full Text] [Related]
26. Familial richner-Hanhart syndrome in Kuwait: twelve-year clinical reassessment by a multidisciplinary approach. el-Badramany MH; Fawzy AR; Farag TI Am J Med Genet; 1995 Oct; 60(5):353-5. PubMed ID: 8546145 [No Abstract] [Full Text] [Related]
27. Dietary management of oculocutaneous tyrosinemia in an 11-year-old child. Ney D; Bay C; Schneider JA; Kelts D; Nyhan WL Am J Dis Child; 1983 Oct; 137(10):995-1000. PubMed ID: 6225330 [TBL] [Abstract][Full Text] [Related]
28. [Richner-Hanhart's syndrome or oculo-cutaneous tyrosinosis (about one case) (author's transl)]. Larrègue M; de Giacomoni P; Bressieux JM; Odièvre M Ann Dermatol Venereol; 1979 Jan; 106(1):53-62. PubMed ID: 485016 [TBL] [Abstract][Full Text] [Related]
29. Successful dietary control of tyrosinemia II. Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199 [TBL] [Abstract][Full Text] [Related]
30. Richner-Hanhart syndrome (tyrosinemia II): early diagnosis of an incomplete presentation with unusual findings. Viglizzo GM; Occella C; Bleidl D; Rongioletti F Pediatr Dermatol; 2006; 23(3):259-61. PubMed ID: 16780475 [TBL] [Abstract][Full Text] [Related]
31. Tyrosinaemia type II (Richner-Hanhart syndrome)--report of two cases treated with etretinate. Fraser NG; MacDonald J; Griffiths WA; McPhie JL Clin Exp Dermatol; 1987 Nov; 12(6):440-3. PubMed ID: 2974325 [No Abstract] [Full Text] [Related]
32. [2 cases of type II tyrosinosis (Richner-Hanhart syndrome)]. Roussat B; Fournier F; Besson D; Godde-Joly D Bull Soc Ophtalmol Fr; 1988; 88(6-7):751-7. PubMed ID: 2907308 [No Abstract] [Full Text] [Related]
33. Tyrosinaemia II. Colditz PB; Yu JS; Billson FA; Rogers M; Molloy HF; O'Halloran M; Wilcken B Med J Aust; 1984 Aug; 141(4):244-5. PubMed ID: 6482766 [TBL] [Abstract][Full Text] [Related]
34. Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II). Sayar RB; von Domarus D; Schäfer HJ; Beckenkamp G Ophthalmologica; 1988; 197(1):1-6. PubMed ID: 3054681 [TBL] [Abstract][Full Text] [Related]
36. Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome. Soares DC; Stroparo MN; Lian YC; Takakura CY; Wolf S; Betz R; Kim CA J Inherit Metab Dis; 2017 May; 40(3):461-462. PubMed ID: 27832414 [TBL] [Abstract][Full Text] [Related]
37. The effect of diet on the ophthalmological, clinical and biochemical aspects of Richner-Hanhart syndrome: a morphological ultrastructural study of the cornea and the conjunctiva. Sammartino A; Cerbella R; Cecio A; De Crecchio G; Federico A; Fronterre A Int Ophthalmol; 1987 Aug; 10(4):203-12. PubMed ID: 3654059 [TBL] [Abstract][Full Text] [Related]
38. Dietary treatment of tyrosinemia type I: importance of methionine restriction. Michals K; Matolon R; Wong PW J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680 [TBL] [Abstract][Full Text] [Related]